Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

când este necesară sedarea.

Tratamentul stărilor fobice şi obsesiv-compulsive.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AA04 CLOMIPRAMINUM DRAJ. 10 mg

ANAFRANIL(R) 10 mg 10 mg NOVARTIS PHARMA GMBH
N06AA04 CLOMIPRAMINUM DRAJ. 25 mg

ANAFRANIL(R) 25 mg 25 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________
______________________________________________________________________________

| 129 |N06AA09| AMITRIPTYLINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AA09 AMITRIPTYLINUM CAPS. RET. 25 mg

AMITRIPTILIN 25 R. DESITIN 25 mg DESITIN
N06AA09 AMITRIPTYLINUM COMPR. FILM. 25 mg

AMITRIPTILINA ARENA 25 mg 25 mg ARENA GROUP S.A.

N06AA09 AMITRIPTYLINUM CAPS. RET. 50 mg

AMITRIPTILIN 50 R. DESITIN 50 mg DESITIN

________________________________________________________________________________
______________________________________________________________________________

| 130 |N06AA12| DOXEPINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AA12 DOXEPINUM DRAJ. 25 mg

DOXEPIN 25 mg 25 mg TERAPIA SA

________________________________________________________________________________

______________________________________________________________________________

| 131 |N06AB03| FLUOXETINUM* | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul depresiilor cu sau fără anxietate în